No Data
No Data
Shionogi Buys Back Shares Worth Nearly 12 Billion Yen
Shionogi (TYO:4507) repurchased 1.6 million shares for 11.58 billion yen in the open market from Feb. 1 to 29, according to a Tokyo Stock Exchange filing on Tuesday. The purchases were made as part of
Jefferies Adjusts Shionogi's Price Target to 7,600 Yen From 6,200 Yen, Keeps at Hold
04:09 AM EST, 03/01/2024 (MT Newswires) -- Jefferies Adjusts Shionogi's Price Target to 7,600 Yen From 6,200 Yen, Keeps at Hold
PureTech Founded Entity Akili Announces Positive Results From Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx for Pediatric ADHD Patients in Japan
Express News | Akili Shares Are Trading Higher After the Company Announced That Its Japanese Partner, Shionogi & Co. Ltd, Has Submitted Akili's Digital Therapeutic SDT-001 for Marketing Approval With the Ministry of Health, Labor, and Welfare
Akili Announces Results From Shionogi's Phase 3 Clinical Trial Of Localized Version Of Akili's EndeavorRx For Pediatric ADHD Patients In Japan, Now Under Review For Nationwide Marketing Approval
Japanese Product Now Under Review for Nationwide Marketing ApprovalAkili, Inc. (NASDAQ:AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submi
Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open
Publication Includes Results of the Phase 3 Trial Evaluating Once-Daily Ensitrelvir in Asia Trial Met Primary and Key Secondary Endpoints Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer:
No Data